Miguel Cordon · · 1 min readSG healthcare analytics startup gets $45m injection
Holmusk is a data analytics company aiming to solve complex problems in behavioral health. The company is headquartered in Singapore and New York.
Funding details
- Funding amount: US$45 million
- Lead investor: Veradigm
- Other investors: Heritas Capital, Health Catalyst Capital, Novartis (dRx Capital), Northwell Holdings
- Stage: Series B
- Source
More details
Holmusk→
|
||
| Stage | Amount (US$) | Investors |
| Pre-series A | 9.8 million | Heritas Capital |
| Series A | 21.5 million | Heritas Capital, Optum Ventures, Health Catalyst Capital |
| Series B | 45 million | Veradigm, Heritas Capital, Northwell Holdings, Novartis (dRx Capital), Health Catalyst Capital |
| Total | 76.3 million | |
See also: Temasek-backed Halodoc enabled sale of restricted drugs
Editing by Dhania Putri Sarahtika
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
